Symptomatic Myocarditis Post COVID-19 Vaccination

Palak Patel; Dhaval Desai; Nagapratap Ganta; Satish Tadepalli; Priyaranjan Kata; Anish Kanukuntla; Matthew Schoenfeld; Bharath Sathya; Arthur Okere

doi:10.7759/cureus.24052

Symptomatic Myocarditis Post COVID-19 Vaccination

Cureus. 2022 Apr 11;14(4):e24052. doi: 10.7759/cureus.24052. eCollection 2022 Apr.

Authors

Palak Patel¹, Dhaval Desai^{2

3}, Nagapratap Ganta¹, Satish Tadepalli¹, Priyaranjan Kata⁴, Anish Kanukuntla¹, Matthew Schoenfeld⁵, Bharath Sathya⁶, Arthur Okere⁷

Affiliations

¹ Internal Medicine, Hackensack Meridian Health Ocean University Medical Center, Brick, USA.
² Cardiovascular Disease, Jersey Shore University Medical Center, Neptune, USA.
³ Internal Medicine, Trinitas Regional Medical Center, Elizabeth, USA.
⁴ Internal Medicine, Rutgers Health Community Medical Center, Toms River, USA.
⁵ Interventional Cardiology, Jersey Shore University Medical Center, Neptune, USA.
⁶ Cardiology, Jersey Shore University Medical Center, Neptune, USA.
⁷ Cardiology, Hackensack Meridian Health Ocean University Medical Center, Brick, USA.

Abstract

There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) COVID-19 vaccines. We present a case series of myopericarditis post mRNA (Moderna) and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccines. We intend to highlight the importance of early diagnosis and treatment of vaccine-related myocarditis to reduce mortality and morbidity.

Keywords: covid-19; johnson & johnson; moderna; myocarditis; vaccine; vaccine adverse event reporting system.

Publication types

Case Reports